1995
DOI: 10.1016/0960-894x(95)00362-w
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic inhibitors of interleukin-6 I: 2,3,7,8-tetrahydro-4-aryl-1H-cyclopent [e] imidazo [1,2-a]- pyridin-5(6H)-one and related compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1999
1999
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…As IL-6 participates in various cellular and physiological responses during the inflammatory reaction [21], IL-6 inhibitors can be used in treatment of psychiatric disorders, Alzheimer's disease, diabetes, cancer, depression SAR and QSAR in Environmental Research 885 and rheumatoid arthritis [22][23][24]. Small compounds that are identified as IL-6 inhibitors (Figure 2) include nitrogen-containing benzophenones [25], β-chloro-vinyl chalcones [26,27], 4-styryl-coumarin derivatives [28], derivatives of N-aryl urea [29], methoxylated chalcones [30], thalidomide analogues [31], pyrazolo [3,4-b]pyridines [32], 3,5-diaryl pyridines and meta-terphenyls [33], 2,2-bisaminomethylated aurone analogues [34], pyrazole chalcones [35] and pyridine-5(6H)-one analogues [36]. Tocilizumab, an anti-interleukin-6 receptor antibody, has been approved for the treatment of rheumatoid arthritis, Castleman's disease and juvenile idiopathic arthritis [37].…”
Section: Introductionmentioning
confidence: 99%
“…As IL-6 participates in various cellular and physiological responses during the inflammatory reaction [21], IL-6 inhibitors can be used in treatment of psychiatric disorders, Alzheimer's disease, diabetes, cancer, depression SAR and QSAR in Environmental Research 885 and rheumatoid arthritis [22][23][24]. Small compounds that are identified as IL-6 inhibitors (Figure 2) include nitrogen-containing benzophenones [25], β-chloro-vinyl chalcones [26,27], 4-styryl-coumarin derivatives [28], derivatives of N-aryl urea [29], methoxylated chalcones [30], thalidomide analogues [31], pyrazolo [3,4-b]pyridines [32], 3,5-diaryl pyridines and meta-terphenyls [33], 2,2-bisaminomethylated aurone analogues [34], pyrazole chalcones [35] and pyridine-5(6H)-one analogues [36]. Tocilizumab, an anti-interleukin-6 receptor antibody, has been approved for the treatment of rheumatoid arthritis, Castleman's disease and juvenile idiopathic arthritis [37].…”
Section: Introductionmentioning
confidence: 99%